- Home
- DNP vs ACLX Comparison
DNP vs ACLX Comparison
Compare DNP & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNP
- ACLX
- Stock Information
- Founded
- DNP 1986
- ACLX 2015
- Country
- DNP United States
- ACLX United States
- Employees
- DNP N/A
- ACLX N/A
- Industry
- DNP Investment Managers
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- DNP Finance
- ACLX Health Care
- Exchange
- DNP Nasdaq
- ACLX Nasdaq
- Market Cap
- DNP 3.8B
- ACLX 4.4B
- IPO Year
- DNP N/A
- ACLX 2022
- Fundamental
- Price
- DNP $10.18
- ACLX $91.00
- Analyst Decision
- DNP
- ACLX Strong Buy
- Analyst Count
- DNP 0
- ACLX 9
- Target Price
- DNP N/A
- ACLX $117.78
- AVG Volume (30 Days)
- DNP 479.6K
- ACLX 384.8K
- Earning Date
- DNP 01-01-0001
- ACLX 11-05-2025
- Dividend Yield
- DNP 7.88%
- ACLX N/A
- EPS Growth
- DNP N/A
- ACLX N/A
- EPS
- DNP 2.30
- ACLX N/A
- Revenue
- DNP $154,887,179.00
- ACLX $35,898,000.00
- Revenue This Year
- DNP N/A
- ACLX N/A
- Revenue Next Year
- DNP N/A
- ACLX $220.95
- P/E Ratio
- DNP $4.26
- ACLX N/A
- Revenue Growth
- DNP 3.30
- ACLX N/A
- 52 Week Low
- DNP $8.69
- ACLX $47.86
- 52 Week High
- DNP $10.04
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- DNP 57.16
- ACLX 56.30
- Support Level
- DNP $9.96
- ACLX $85.00
- Resistance Level
- DNP $10.22
- ACLX $90.30
- Average True Range (ATR)
- DNP 0.10
- ACLX 3.87
- MACD
- DNP 0.00
- ACLX -0.15
- Stochastic Oscillator
- DNP 75.66
- ACLX 60.49
About DNP DNP Select Income Fund Inc.
DNP Select Income Fund Inc is a closed-ended investment management fund. The primary investment objectives of the fund are current income and long-term growth of income. Its secondary objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing in the public utility industry.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.